Addressing critical global issues facing humanity, such as climate change, sustainable development and global economic recovery.
Addressing critical global issues facing humanity, such as climate change, sustainable development and global economic recovery.
Addressing critical global issues facing humanity, such as climate change, sustainable development and global economic recovery.
The CKGSB-UC San Diego Joint Biotech Innovation Program is a pioneering course specifically designed to equip CEOs and founders in the life sciences and biotechnology industry with the essential knowledge and connections needed to thrive in this rapidly evolving sector.
Delivered collaboratively by ESCP and CKGSB, this immersive program is tailored for visionary global leaders seeking to navigate the intersection of luxury and technology.
The program will provide practical business strategies to grow, scale, globalize, and potentially exit deep tech ventures and will touch upon the latest insights on deep tech advancements, such as AI, cutting-edge computing, and cybersecurity innovation.
In collaboration with the Stanford Center for Professional Development (SCPD), this CKGSB program equips entrepreneurs, intrapreneurs and key stakeholders with the tools, insights, and skills necessary to lead a new generation of unicorn companies.
Partners
Partners
Partners
Partners
In 2015, we established ourselves as the pioneering business school to introduce programs tailored specifically for unicorn companies in China, collaborating with industry giants like Alibaba, Tencent, JD.com, Baidu, and ByteDance. In 2016, we expanded this ecosystem globally, offering programs for unicorns.
Today, our partnerships extend to renowned institutions such as Columbia Engineering, the Stanford Center for Professional Development, SDA Bocconi, and The Executive Council of Dubai, offering you invaluable insights and strategies for scaling up across diverse international markets.
Alumni
Founders
Companies which have made unicorn status
Companies listed on CB Insights
(2017-2022)